Firebrick Pharma Limited Overview
Get informed when a big investor buys or sells
+ Follow-338.74%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, FRE.AX shows a ROE of -338.74%. That is below the sector sector average of 11.64%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about 11.64%. Firebrick Pharma Limited is at -338.74%, which is lower that average. That is roughly 3011.0% below the sector mean. Use the comparison chart on this page to see how FRE.AX stacks up against individual peers as well.
Check the historical chart to see whether FRE.AX's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Firebrick Pharma Limited with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Firebrick Pharma Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -338.74%) with ownership activity and broader fundamentals.
